Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 3NIH 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neutropenia 1Mycoses 1Leukemia, Biphenotypic, Acute 1Diarrhea 1Bacterial Infections 1

Interventions

Cytarabine 83Methotrexate 59Cyclophosphamide 58Vincristine 47Daunorubicin 46Prednisone 33Mercaptopurine 33Asparaginase 33Dexamethasone 31Doxorubicin 29Gene Expression Profiling 27Etoposide 27pegaspargase 25Radiotherapy 25Filgrastim 25Thioguanine 24Leucovorin 24Flow Cytometry 23merphos 22Hydrocortisone 20Calcium Dobesilate 20Specimen Handling 18Microarray Analysis 16Idarubicin 16Granulocyte Colony-Stimulating Factor 15Peripheral Blood Stem Cell Transplantation 14Busulfan 14Polymerase Chain Reaction 13Mitoxantrone 13Gemtuzumab 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Levofloxacin × Other hematologic neoplasm × Clear all
NCT01371656 2020-12-07

Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation

Children's Oncology Group

Phase 3 Completed
624 enrolled 16 charts
LymphoidOther hematologic neoplasm

Bacterial Infections, Diarrhea, Mycoses, Neutropenia, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡